Skip to main content
Premium Trial:

Request an Annual Quote

Biodesix: Kieran O'Kane, Bobbi Coffin

Biodesix has announced a realignment of its commercial executive team. Effective immediately, current head of strategic marketing Kieran O'Kane will become the company's chief commercial officer, while Bobbi Coffin, currently chief marketing officer, will become the firm's chief growth officer.

After joining the company in 2018, Biodesix said that O'Kane played a leading role in the successful acquisition of Integrated Diagnostics and Oncimmune's laboratory and incidental pulmonology nodule malignancy test, proving instrumental in the subsequent commercial launch of what are now the Nodify XL2 and Nodify CDT tests. He previously worked at various other companies, including NanoString Technologies, Bristol Myers Squibb, and Roche.

Coffin joined Biodesix in 2015 from Exact Sciences where she was VP of commercial marketing and strategy. Prior to that role, she held leadership positions at Precision Therapeutics and Cytyc/Hologic.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.